Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• recognize patients with substance use disorders who would benefit from addition of behavioral treatments such as contingency management.
• directly provide behavioral treatment (such as contingency management) or to make informed referrals to other providers who provide behavioral treatment for substance use disorders.

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to identify, diagnose and treat tobacco use disorder in their practice as an essential part of their practice

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• identify that the use of illicit psychostimulants such as methamphetamine and cocaine has increased, particularly among those using opioids
• recognize that those patients with stimulant use disorders may not necessarily spontaneously report that they are also using opioids
• identify that stimulant co-use specifically methamphetamine, and stimulant co-involvement in overdose fatalities, including among people with opioid use disorder, are of growing concern in the USA and around the world

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• describe the current status of the evidence on the therapeutic use of marijuana and psychedelics in the treatment of mental illnesses
• identify strategies aiming at optimizing the discussion and education of patients with regards to the available evidence mentioned above

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• identify that numerous classes of prescription medications can interact with alcohol, including antibiotics, antidepressants, antihistamines, barbiturates, benzodiazepines, histamine H2 receptor antagonists, muscle relaxants, nonnarcotic pain medications and anti-inflammatory agents, opioids, and warfarin
• recognize that those patients with alcohol use may not necessarily spontaneously report that they are also using other CNS active medications
• identify pharmacokinetic and pharmacodynamic interactions of the above medications with each other and with alcohol
• recognize that many over-the-counter and herbal medications can cause negative effects when taken with alcohol.

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• identify and diagnosis of opioid use disorder
• identify pharmacologic interventions for opioid use disorder
• multidisciplinary approach to treat pregnant patient with opioid use disorder

Objectives: The learning objectives for this activity has been designed to address clinician competence. Upon conclusion of the activity participants should be able to:

• explain why treatment selection is an ethical act
• describe several relevant clinician virtues in psychiatric treatment selection
• show how attention to clinician virtues assist in addressing patient values in evidence-based practice.